Cytek BioSciences CTKB 深 滬
等待開盤 07-24 09:30:00 美东时间
3.37
+0.120
+3.69%
華盛通- 最 高3.435
- 今 開3.31
- 成交量 76.50万股
- 最 低 3.2601
- 昨 收 3.25
- 總市值 4.28亿
- 52周最高 7.63
- 市盈率 靜 --
- 換手率 0.60%
- 52周最低 2.37
- 委 比 -11.49%
- 總股本 1.27亿
- 歷史最高 28.70
- 量 比 1.14
- 振 幅 5.38%
- 歷史最低 2.37
- 每 手 1
- 風險率 1.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
Cytek Biosciences announced it will release its Q2 2025 financial results after market close on August 6, 2025. Management will host a webcast conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments, and outlook. A live audio webcast will be available on the company’s Investor Relations website. Cytek Biosciences is a leading provider of advanced cell analysis solutions, leveraging its patented Full Spectrum Profi...
07-23 20:05
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Cytek Biosciences, Inc. debuted the Cytek Aurora™ Evo system, a high-performance flow cytometer that enhances its predecessor's reliability and reproducibility with added high-throughput and automation features. The system leverages Cytek’s Full Spectrum Profiling™ technology, improving sample throughput, automating maintenance, and enabling detection of small particles like extracellular vesicles. Designed for modern research demands, the Cytek ...
05-29 21:00
美股大行评级 | 拼多多遭多家大行下调评级！Redburn Atlantic首予博通"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1134767544930545665.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持AnaptysBio(ANAB)"买入"评级，目标价从54美元升至90美元</p> <p>• Canaccord Genuity：维持Bridger Aerospace Gr(BAER)"买入"评
05-29 09:53
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock
In the preceding three months, 4 analysts have released ratings for Cytek Biosc...
05-29 03:00
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
05-28 20:24
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
Cytek Biosciences, Inc. (NASDAQ: CTKB) announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach. Cytek's management will engage in a fireside chat on June 11 at 11:40 a.m. PT / 2:40 p.m. ET. The webcast will be accessible on the company's website. Cytek is a leading provider of cell analysis solutions, utilizing its patented Full Spectrum Profiling™ technology to offer advanced tools for research an...
05-28 20:05
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
Cytek Biosciences: Earnings Call Reveals Mixed Fortunes
Cytek Biosciences, Inc. (($CTKB)) has held its Q1 earnings call. Read on for th...
05-10 08:48
